Category News

Malaria is a life-threatening disease caused by parasites of the genus Plasmodium, transmitted by the bite of infected mosquitoes. The most deadly form of malaria is caused by Plasmodium falciparum, which is responsible for about 95% of all malaria cases…

Nuno Silva was one of the Portuguese researchers to win the CaixaResearch Health Research 2023 award, a competition run by the “la Caixa” Foundation.

Nuno Dinis Alves and Sara Calafate, researchers from ICVS at the School of Medicine, are distinguished this Thursday, November 16th, with the Maria de Sousa prize.

The Grünenthal Dor Prize 2022, in basic research, was awarded to work carried out by researchers from the ICVS ReNEU and NoPain thematic teams, published in the Stem Cells & Development journal.

The ICVS researchers are part of 65 UMinho scientists who are in the 2% most cited in the world over the last year, according to a study by Stanford University (USA) and the Elsevier editorial group.

“Discovering the Connections between Space and Human Health”, the activity developed by ICVS researchers was a success at the European Researchers' Night, an event that took place last Friday, September 29th, at Altice Forum Braga.

ICVS researcher Miguel Quintas Neves has received the award for best scientific work of the year by the European Society of Neuroradiology (ESNR), on 21.09.2023 (World Alzheimer’s Disease Day), in Vienna, Austria, during the Society’s annual congress. “Divergent magnetic resonance…

In a paper recently published in the scientific journal Pain, researchers from the Institute of Life and Health Sciences (ICVS) developed and validated a new animal model of experimental osteoarthritis that mimics the radiological progression of the disease

A team of ICVS researchers saw their work about coffee consumption and its effects on the brain published in the journal Frontiers of Behavioral Neuroscience.

Start-up Karion Therapeutics, funded by ICVS researcher's Marta Costa and Fátima Baltazar, dedicated to an innovative treatment for aggressive cancers, is the winner of the Arqus International Innovators Award.